Updated: BioSpace's List of Q4 2018 Life Sciences IPOs

Published: Oct 19, 2018 By

Q4 IPO Filings and Proceeds, Updated 10/19/2018

Know of an IPO since Oct. 1, 2018 that we missed? Email us at news@biospace.com. 

Date Company Name Amount (USD) Company HQ Research Focus
10/19/18 LogicBio Therapeutics $70M Raised Cambridge, MA Genome editing in rare diseases for pediatric patients
10/18/18 PhaseBio Pharmaceuticals, Inc. $46M Raised Malvern, PA Novel therapies to treat orphan diseases, especially cardiopulmonary 
10/18/18 Osmotica Pharmaceutical $46.6M Raised Bridgewater, NJ Generic drugs for neurology and women's health
10/17/18 SI-BONE, Inc. $108M Raised Santa Clara, CA Medical device company treating SI joint pain with the iFuse Implant System®
10/12/18 Equillium, Inc. $65.4M Raised La Jolla, CA Monoclonal antibodies to treat severe immuno-inflammatory diseases
10/11/18 Allogene Therapeutics $372.6M Raised South San Francisco, CA Allogenic CAR-T therapies for blood cancer and solid tumors
10/10/18 Hoth Therapeutics $13M Filed New York City, NY Proprietary therapeutics for atopic dermatitis 
10/5/18 Axonics Modulation Technologies $86.25M Filed Irvine, CA Medical devices with innovative neuromodulation platform for urinary and fecal dysfunction
10/4/18 Guardant Health $237.5M Raised Redwood City, CA Blood tests for early and recurrent cancer detection and treatment selection
10/4/18 Kodiak Sciences Inc. $90M Raised Palo Alto, CA Antibody bipolymer conjugates in retinal disease
10/4/18 Orchard Therapeutics $172.5M Filed London, UK Gene therapy for primary immune deficiencies & inherited metabolic disorders
10/3/18 Twist Bioscience $86.25M Filed San Francisco, CA Silicon-based DNA synthesis platform

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Click here to get the latest life sciences news straight to your inbox. Subscribe now to our FREE newsletters

Back to news